SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-012098
Filing Date
2020-06-29
Accepted
2020-06-29 16:06:29
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1028792
2 ex23-1.htm EX-23.1 4094
3 ex31-1.htm EX-31.1 16760
4 ex31-2.htm EX-31.2 16769
5 ex32-1.htm EX-32.1 5104
6 ex32-2.htm EX-32.2 5095
  Complete submission text file 0001493152-20-012098.txt   4018497

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE vbio-20200331.xml EX-101.INS 511812
8 XBRL SCHEMA FILE vbio-20200331.xsd EX-101.SCH 50785
9 XBRL CALCULATION FILE vbio-20200331_cal.xml EX-101.CAL 55817
10 XBRL DEFINITION FILE vbio-20200331_def.xml EX-101.DEF 144027
11 XBRL LABEL FILE vbio-20200331_lab.xml EX-101.LAB 366660
12 XBRL PRESENTATION FILE vbio-20200331_pre.xml EX-101.PRE 266599
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-53832 | Film No.: 20997541
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services